OTCMKTS:BIOQ Bioqual (BIOQ) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free BIOQ Stock Alerts $72.50 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$72.50▼$72.5050-Day Range$70.00▼$80.0052-Week Range$59.00▼$80.00VolumeN/AAverage Volume39 shsMarket CapitalizationN/AP/E Ratio67.76Dividend Yield0.69%Price TargetN/A Stock AnalysisStock AnalysisChartDividendEarningsFinancialsStock AnalysisChartDividendEarningsFinancials Get Bioqual alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Bioqual Stock (OTCMKTS:BIOQ)Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.Read More BIOQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOQ Stock News HeadlinesApril 22, 2024 | businesswire.comBIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2024January 23, 2024 | finance.yahoo.comBioqual Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2024May 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.October 20, 2023 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2024September 20, 2023 | finance.yahoo.comBIOQUAL Presents Financial Results for Fiscal Year 2023April 26, 2023 | finanznachrichten.deBIAL Foundation: BIAL Award in Biomedicine worth 300,000 EurosApril 21, 2023 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2023January 20, 2023 | msn.comChino Commercial Bancorp GAAP EPS of $0.49, revenue of $4.06MMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.January 20, 2023 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2023October 27, 2022 | wsj.comBioqual Inc.October 21, 2022 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2023October 6, 2022 | finance.yahoo.comBIOQUAL, Inc. Announces New CFOSeptember 27, 2022 | finance.yahoo.comBIOQUAL Declares DividendSeptember 21, 2022 | nz.finance.yahoo.comFood Packaging Technology & Equipment Market to Generate $83.52 Billion by 2030: The Brainy InsightsSeptember 21, 2022 | stockhouse.comKeysight's 224G Ethernet Test Solutions Enable System-on-a-Chip Makers to Validate Next Generation High-speed Digital Interface TechnologySeptember 21, 2022 | yahoo.comToddler loves helping with laundry — until he’s given his favorite blanketSeptember 21, 2022 | yahoo.comParents’ ‘hygiene budgets’ for their kids stirs controversy on TikTokSeptember 19, 2022 | finance.yahoo.comBIOQUAL Presents Financial Results for Fiscal Year 2022May 16, 2022 | stockhouse.comCelsion Corporation Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 11, 2022 | yahoo.comDave Mustaine Blasts Aggressive Security Guard During Megadeth Concert: WatchMay 9, 2022 | morningstar.comBIOQUAL, Inc. Announces Creation of the Role of Chief Scientific OfficerMay 9, 2022 | finance.yahoo.comBIOQUAL, Inc. CFO Announces Retirement and Appointment to BIOQUAL BoardApril 21, 2022 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2022March 31, 2022 | nz.finance.yahoo.comCelsion Corporation Reports 2021 Financial Results and Provides Business UpdateJanuary 31, 2022 | finance.yahoo.comCelsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine CandidateJanuary 21, 2022 | finance.yahoo.comBIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2022See More Headlines Receive BIOQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/22/2024Today5/03/2024Fiscal Year End5/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolOTCMKTS:BIOQ CUSIP09065J101 CIK719711 Webwww.bioqual.com Phone(240) 404-7654FaxN/AEmployees114Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.07 Trailing P/E Ratio67.76 Forward P/E RatioN/A P/E GrowthN/ANet Income$840,000.00 Net Margins1.51% Pretax Margin-1.20% Return on Equity2.48% Return on Assets1.56% Debt Debt-to-Equity RatioN/A Current Ratio4.20 Quick Ratio4.20 Sales & Book Value Annual Sales$62.66 million Price / SalesN/A Cash Flow$15.01 per share Price / Cash Flow4.83 Book Value$42.04 per share Price / Book1.72Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.26 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Mark G. Lewis Ph.D. (Age 69)Chairman of the Board, CEO & President Mr. Charles C. Kirk Jr.CPA, Chief Financial OfficerMitch FranklinChief Operating OfficerMs. Hanne Andersen-Elyard Ph.D.Chief Scientific OfficerKey CompetitorsStarpharmaOTCMKTS:SPHRYInotivNASDAQ:NOTVHedgePath PharmaceuticalsOTCMKTS:HPPIbioAffinity TechnologiesNASDAQ:BIAFYS BiopharmaNASDAQ:YSView All Competitors BIOQ Stock Analysis - Frequently Asked Questions How have BIOQ shares performed in 2024? Bioqual's stock was trading at $64.00 at the beginning of 2024. Since then, BIOQ stock has increased by 13.3% and is now trading at $72.50. View the best growth stocks for 2024 here. How were Bioqual's earnings last quarter? Bioqual, Inc. (OTCMKTS:BIOQ) announced its quarterly earnings results on Monday, April, 22nd. The company reported $0.31 earnings per share (EPS) for the quarter. The business had revenue of $15.34 million for the quarter. Bioqual had a net margin of 1.51% and a trailing twelve-month return on equity of 2.48%. How often does Bioqual pay dividends? What is the dividend yield for Bioqual? Bioqual announced an annual dividend on Friday, September 22nd. Shareholders of record on Friday, October 6th will be paid a dividend of $0.50 per share on Friday, October 27th. This represents a dividend yield of 0.83%. The ex-dividend date is Thursday, October 5th. Read our dividend analysis for BIOQ. Is Bioqual a good dividend stock? Bioqual (OTCMKTS:BIOQ) pays an annual dividend of $0.50 per share and currently has a dividend yield of 0.69%. The dividend payout ratio is 46.73%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for BIOQ. How do I buy shares of Bioqual? Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOQ) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsFW: 234x GainWeiss RatingsUrgent Nvidia WarningAltimetryCould Your Accounts Be Frozen?Allegiance GoldDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioqual, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
